Stay updated on Dupilumab for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Dupilumab for Eosinophilic Gastritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study protocol information for a clinical trial on Eosinophilic Gastritis and the addition of collaborators and a revision number. Notably, the specific details about participant criteria and treatment regimens have been deleted.SummaryDifference30%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check57 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check86 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Dupilumab for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.